Report an error   

Submitted: 22 November 2006 Modified: 25 June 2018
HERDIN Record #: PCHRD112106071103

A comparison on the efficacy and safety of different insulin regimens in type 2 diabetes mellitus patients undergoing coronary artery bypass graft surgery in St. Luke's Medical Center.

1Cherrie Gail R. Lumapas,
2Joselynna Quimpo,
3Gabriel Jasul,
4Jay Jayme-Wohldorf


OBJECTIVE: This study aims to determine the efficacy and safety of different insulin regimens used in the peri-operative period in diabetics undergoing Coronary Artery Bypass Graft (CABG).

STUDY DESIGN: Analytical Cross-sectional Study

METHODOLOGY: A chart review of Type 2 diabetics who underwent CABG in SLMC from March 2003 to September 2004 was done. The subjects were grouped according to the insulin regimen received during the peri-operative period. The mean blood glucose levels and total insulin infused, frequency of hypoglycemia, duration of CCU stay and post-op complications for each group were compared and analyzed statistically.

RESULTS: 39 patients met the inclusion criteria. 19 were on IV insulin drip alone, 15 on insulin glargine plus insulin drip, and 5 on isophane insulin plus insulin drip. The insulin glargine group had the lowest mean peri-op blood glucose level, lowest post-op insulin drip rate and lowest incidence of hypoglycemia. The isophane insulin group had the lowest insulin infusion rate during the intra-op period. The group on insulin drip alone had the highest peri-op blood glucose levels, insulin infusion rate and complication rate. However, no significant differences were seen among the three groups after statistical analysis.

CONCLUSION: This study suggests that insulin glargine plus intravenous insulin infusion used during CABG resulted in lower blood glucose levels throughout the peri-operative period. Three patients on modified Portland Protocol had lower blood glucose levels than those on the traditional insulin drip sliding scale. However, no significant differences were noted among the groups, because of the limitations in the sample size.

RECOMMENDATIONS: More experience with the use of insulin glargine may further demonstrate its efficacy and safety during the peri-operative period. Thus, we recommend that a head-on comparison between the use of insulin glargine and Portland Protocol during surgery be done in a larger sample size.

Publication Type:
Publication Sub Type:
Journal Article, Original
Philippine Journal of Internal Medicine
Six times a year (6x/year)
Publication Date:
January-February 2006
Philippine College of Physicians

LocationCall NumberAvailable FormatAvailability
Philippine Council for Health Research and Development Library Box No. 48 Fulltext Print Format (Request Document)
Philippine Council for Health Research and Development Fulltext pdf (Request Document)
1. French, Gordon . "Clinical management of diabetes mellitus during anesthesia and surgery" Acta Aneesthesiologica Scandinavica 4, 383, April 2003
2. Rossini, A , Hare, J W. "How to control the blood sugar levels in a surgical diabetic patient" Archives of Surgery 111, 945, 1976
3. Marks, Jennifer . "Peri-operative management of diabetes" American Family Physician 67, 1, January 2003
4. Golden, S H, Pearl-Vigilance, C , Kao, W , Brancote, F . "Peri-operative glycemic control and the risk of infectious complications in a cohort of adults with diabetes" Diabetes Care 22, 1408, 1999
5. McMurry Jr, J F. "Wound healing with diabetes mellitus. Better glucose control for better wound healing in diabetes." Surgical Clinic of North America 64, 769, 1984
6. Belden, Helen . "Insulin protocol lowers risks for diabetic heart patients" Drug Topics Archive 148, 54, March 2004
7. Van den Berghe, G , Wouters, P . "Weekers: Intensive Insulin Therapy in Critically ill patients" The New England Journal of Medicine 345, 1359, 2001
8. Furnary, A P, Gao, G , Grunkemeier, G L, Starr, A . "Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting" Journal of Thoracic Cardiovascular Surgery 125, 1007, 2003
9. Furnary, A P, Zerr, K , Grunkemeier, G L, Starr, A . "Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infections in diabetic patients after cardiac surgical procedures" Annals of Thoracic Surgery 67, 362, 1999
10. "ACE Position statement on in-patients diabetes and metabolic control" Endocrinology Practice 10(1): 78, 2004
11. Pace, Benjamin , Cheong, Raymond . "Peri-operative management of the diabetic patient" Medicine , September 2003
12. Insulin Glargine. London New Drug Group APC/DTC Guidance Document, August 2002 London:
13. Yki, J , Dressler, A , Ziemen, M . "Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study group" Diabetes Care 23, 1130, 2000
14. Ratner, R , Hirsch, I , et al, . "Less hypoglycemia with insulin glargine in intensive insulin therapy for type I diabetes" Medscape Critical Care 5(1): 2004
15. Bucerlus, J , Gummert, J F, Walther, T , Doll, N , Falk, V , Onnasch, J F, Barten, M J, Mohr, F W. "Impact of diabetes mellitus on cardiac durgery outcomes" Thorac Cardiovasc Surgery 51, 11, 2001
16. Rosenstock, J , Schwartz, S , Clark, C , Park, G , Donley, D , Edwards, M . "Basal insulin therapy in type 2 diabetes. A 28 week comparison of insulin glargine and NPH insulin" Diabetes Care 24, 4, 2001
17. Zerr, K J. "Glucose control lowers risk of wound infections in diabetics after open heart surgery." Annals of Thoracic Surgery 63, 356, 1997
18. Vora, A , Saleem, T . "Improved perioperative glycemic control by continuous insulin infusion under supervision of an endocrinologist does not increase costs in patients with diabetes" Endocrinie Practice 10, 2, 2004
19. Heinemsnn, L . "Time-action profile of the long acting insulin analog insulin glargine in comparison with the use of NPH and placebo" Diabetes Care 23, 644, 2003
20. Trence, D , Kelly, J , Hirsch, I . "The rationale and management of hyperglycemia for in-patients with cardiovascular disease: Time for change" Journal of Clinical Endocrinology and Metabolism 88, 6, 2003
21. Is Low blood glucose (Hypoglycemia) dangerous? Joslin Diabetes Center Guidelines.
22. Davidson, M . Hypoglycemia in Adults.. Manual of Endocrinology and Metabolism, 3rd ed Lippincott Williams & Wilkins, 2002.
23. Desouza, C . "Association of hypoglycemia and cardiac ischemia: A Study based on continuous monitoring - Emerging treatment and technologies" Diabetes Care , 2003
24. De Fronzo, P A, Hendler, R , Christensen, N . "Stimulation of counter regulatory hormonal response in diabetic man by a Fall in glucose concentration" Diabetes 29, 125, 1980
25. Heller, S R. "Abnormalities of the electrocardiogram during hypoglycemia: The Cause of the dead syndrome?" International Journal of Clinical Practice (Supplement): 27, 2002